Medical research
New treatment aids weight loss, improves diabetes in monkeys
(HealthDay)—A new, lab-created antibody that mimics the action of a naturally occurring molecule causes weight loss in monkeys, researchers report.
Nov 28, 2012
0
0
News tagged with amgen
Medications
FDA approves lower-cost alternative to biotech drug Humira
Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.
Sep 23, 2016
0
3
Medical research
Mice studies in space offer clues on bone loss
Astronauts know their bodies will be tested during time spent on the International Space Station, from the 15 daily sunrises and sunsets wreaking havoc on their circadian rhythms to the lack of gravity that weakens bone density ...
May 26, 2016
0
41
Medications
Valeant steps in to work on psoriasis drug with AstraZeneca
Canadian drugmaker Valeant will work with British competitor AstraZeneca on a potential treatment for psoriasis a few months after biotech giant Amgen said it was ending research on the drug because of a link to suicidal ...
Sep 1, 2015
0
3
Medications
Medicare will cover expensive new leukemia medication
(HealthDay)—Medicare will pay for a new, expensive cancer medication that costs about $178,000 for a standard course of treatment, the Obama administration says.
Aug 11, 2015
0
10
Medications
FDA panel backs Amgen cholesterol drug for some patients (Update)
Federal health advisers said Wednesday that a highly-anticipated cholesterol-lowering drug from Amgen Inc. should be approved for patients with dangerously high levels of the artery-clogging substance.
Jun 10, 2015
0
3
Oncology & Cancer
Amgen says a study found its cancer drug more effective than rival drug
Amgen Inc., the Thousand Oaks, Calif., biotech giant, said Sunday a new study has found its cancer drug Kyprolis is far more effective in treatment of relapsed multiple myeloma than its chief rival.
Mar 3, 2015
0
6
Cardiology
High LDL cholesterol remains common among US adults
(HealthDay)—High low-density lipoprotein (LDL) cholesterol remains common among U.S. adults, according to a study published in the Sept. 1 issue of The American Journal of Cardiology.
Sep 17, 2013
0
0
Oncology & Cancer
Response-guided neoadjuvant chemo beneficial in breast CA
(HealthDay)—For patients with early breast cancer, a response-guided neoadjuvant chemotherapy approach seems beneficial, according to a study published online Sept. 3 in the Journal of Clinical Oncology.
Sep 7, 2013
0
0
Medications
Xgeva approved for rare, non-malignant tumor
(HealthDay)—Xgeva (denosumab) has been approved by the U.S. Food and Drug Administration to treat giant cell tumor of the bone (GCTB), a rare tumor that's most often non-cancerous.
Jun 13, 2013
0
0
